Skip to main content

New Product Watch: Oct 25, 2011

Premium

Microarrays Inc. this week launched three MI PathArray assays for studying targeted biological pathways. The new arrays cover pathways associated with apoptosis, growth factors, and inflammation. Each slide contains four subarrays with an average coverage of three probes per gene plus controls and probes for data normalization. On its website, MI says it plans to introduce arrays for studying cancer and transcription factors in the future. The company also plans to eventually sell kits and hardware for sample preparation, processing, and array hybridization.

BioArray News spoke with CEO Joel Peek about the new offering earlier this month (BAN 10/11/11).

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.